ArticlemedRxiv : the preprint server for health sciences2026
The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis.
Daisuke Yasui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.